Puzzle Medical raises $25M Series A to fund percutaneous heart pump
2023-02-27
Cordis-X, a cardiovascular-focused investment vehicle, led the funding round. Ajax Health, Hellman & Friedman and KKR back Cordis-X. Longview Ventures, Desjardins Capital and BDC Capital’s Thrive Venture Fund participated, too, along with existing investors.
“We are thrilled to have closed our Series A funding round and to have the support of such a renowned syndicate of investors,” said Jade Doucet-Martineau, co-founder and CEO of Puzzle Medical Devices. “This milestone achievement is a reflection of the team’s dedication and execution capability and will allow us to continue to execute on our mission of transforming the treatment of advanced heart failure.”
Montreal, Quebec–based Puzzle Medical is developing a long-term, percutaneous, transcatheter heart pump for people with advanced heart failure. With a modular design, the device allows for safe implantation to support renal and cardiac function. Its 4mm pumps anchor in parallel in the descending aorta.
The company intends to use the funding primarily to complete its human feasibility study. Puzzle Medical also intends to allocate funds toward expanding development efforts and attracting talent. In addition to its fundraising, the company added Duke Rohlen, Aftab Kherani and Maria Berkman to its board of directors.
“What the Puzzle team has accomplished in a few short years is remarkable,” Rohlen, executive chair of Cordis and CEO of Cordis-X and Ajax Health, said. “They’ve developed a truly novel solution to one of the most serious and difficult challenges in cardiovascular care.”
Founded in 2018, Puzzle Medical was on our list of startups to look out for in 2020.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
靶点
-药物
-热门报告
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。